Induction of the matrix metalloproteinase-2 activation system in arteries by tensile stress. Involvement of the p38 MAP-kinase pathway

Pathology Research and Practice

Volumn 203, Issue 3, 2007, Pages 135-143

  Grabellus, Florian ^a   Worm, Karl ^a   Schmid, Kurt W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Extracellular matrix; Matrix metalloproteinases; Mitogen activated protein kinases; Signal transduction; Vascular remodeling

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GELATINASE; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY WALL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SWINE; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 33847296622     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.01.001     Document Type: Article

References (31)

1. Alexander J.P., and Acott T.S. Involvement of the Erk-MAP kinase pathway in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs. Invest. Ophthalmol. Vis. Sci. 44 (2003) 164-169
2. Chakraborti S., Mandal M., Das S., Mandal A., and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol. Cell Biochem. 253 (2003) 269-285
3. Chesler N.C., Ku D.N., and Galis Z.S. Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. Am. J. Physiol. 277 (1999) H2002-H2009
4. Cho A., Graves J., and Reidy M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2527-2532
5. Eskildsen-Helmond Y.E., and Mulvany M.J. Pressure-induced activation of extracellular signal-regulated kinase 1/2 in small arteries. Hypertension 41 (2003) 891-897
6. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90 (2002) 251-262
7. Godin D., Ivan E., Johnson C., Magid R., and Galis Z.S. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 102 (2000) 2861-2866
8. Ingber D.E. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ. Res. 91 (2002) 877-887
9. Itoh Y., Takamura A., Ito N., Maru Y., Sato H., Suenaga N., Aoki T., and Seiki M. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 20 (2001) 4782-4793
10. Jackson Z.S., Gotlieb A.I., and Langille B.L. Wall tissue remodeling regulates longitudinal tension in arteries. Circ. Res. 90 (2002) 918-925
11. Kumar S., Boehm J., and Lee J.C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2 (2003) 717-726
12. Lehoux S., Lemarie C.A., Esposito B., Lijnen H.R., and Tedgui A. Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodelling. Circulation 109 (2004) 1041-1047
13. London G.M., Marchais S.J., Guerin A.P., Metivier F., and Adda H. Arterial structure and function in end-stage renal disease. Nephrol. Dial. Transplant. 17 (2002) 1713-1724
14. Meng X., Mavromatis K., and Galis Z.S. Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair. Exp. Mol. Pathol. 66 (1999) 227-237
15. Morgunova E., Tuuttila A., Bergmann U., and Tryggvason K. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc. Natl. Acad. Sci. USA 99 (2002) 7414-7419
16. Munshi H.G., Wu Y.I., Mukhopadhyay S., Ottaviano A.J., Sassano A., Koblinski J.E., Platanias L.C., and Stack M.S. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J. Biol. Chem. 279 (2004) 39042-39050
17. Osenkowski P., Toth M., and Fridman R. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J. Cell. Physiol. 200 (2004) 2-10
18. Ravingerova T., Barancik M., and Strniskova M. Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology. Mol. Cell. Biochem. 247 (2003) 127-138
19. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., and Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370 (1994) 61-65
20. Schultz R.M. Potential of p38 MAP kinase inhibitors in the treatment of cancer. Prog. Drug Res. 60 (2003) 59-92
21. Sotoudeh M., Li Y.S., Yajima N., Chang C.C., Tsou T.C., Wang Y., Usami S., Ratcliffe A., Chien S., and Shyy J.Y. Induction of apoptosis in vascular smooth muscle cells by mechanical stretch. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H1709-H1716
22. Spurrell B.E., Murphy T.V., and Hill M.A. Intraluminal pressure stimulates MAPK phosphorylation in arterioles: temporal dissociation from myogenic contractile response. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H1764-H1773
23. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol. 200 (2003) 448-464
24. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17 (2001) 463-516
25. Surapisitchat J., Hoefen R.J., Pi X., Yoshizumi M., Yan C., and Berk B.C. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: inhibitory crosstalk among MAPK family members. Proc. Natl. Acad. Sci. USA 98 (2001) 6476-6481
26. Vlahos C.J., McDowell S.A., and Clerk A. Kinases as therapeutic targets for heart failure. Nat. Rev. Drug Discov. 2 (2003) 99-113
27. von Offenberg S.N., Cummins P.M., Birney Y.A., Cullen J.P., Redmond E.M., and Cahill P.A. Cyclic strain-mediated regulation of endothelial matrix metalloproteinase-2 expression and activity. Cardiovasc. Res. 63 (2004) 625-634
28. Xie Z., Singh M., and Singh K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J. Biol. Chem. 279 (2004) 39513-39519
29. Yamaguchi S., Yamaguchi M., Yatsuyanagi E., Yun S.S., Nakajima N., Madri J.A., and Sumpio B.E. Cyclic strain stimulates early growth response gene product 1-mediated expression of membrane type 1 matrix metalloproteinase in endothelium. Lab. Invest. 82 (2002) 949-956
30. Yamawaki H., Lehoux S., and Berk B.C. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation 108 (2003) 1619-1625
31. Zucker S., Drews M., Conner C., Foda H.D., DeClerck Y.A., Langley K.E., Bahou W.F., Docherty A.J., and Cao J. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J. Biol. Chem. 273 (1998) 1216-1222